Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-12-069632)

Filing Details

Accession Number:: 0001104659-12-069632
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-10-17 15:49:21
Reporting Period:: 2012-10-16

Filing Date:: 2012-10-17
Accepted Time:: 2012-10-17 15:49:21
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1029142	Dynavax Technologies Corp	DVAX	Pharmaceutical Preparations (2834)	330728374

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1222013	Mark Kessel	C/O Dynavax Technologies Corp. 2929 Seventh Street, Suite 100 Berkley CA 94710		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.001 Per Share	Disposition	2012-10-16	6,000,000	$4.73	3,031,431	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote

Footnotes

Includes 2,875,136 shares of common stock of the Issuer directly owned by Symphony Capital Partners, L.P. and 156,295 shares of common stock of the Issuer directly owned by Symphony Strategic Partners, LLC. Symphony GP, LLC is the general partner of Symphony Capital GP, L.P., which is the general partner of Symphony Capital Partners, L.P. Mark Kessel is a managing member of Symphony GP, LLC and Symphony Strategic Partners, LLC.